| 摘要 |
<p>The invention relates generally to changes in gene expression associated with renal disease, with inflammation, and with cell growth arrest, and to methods of using differentially expressed genes or gene products as drug discovery agents, diagnostic tools or as targets in therapeutic intervention. Specifically, the invention relates to a novel human gene that corresponds to an mRNA which is differentially-regulated in kidney tissue from patients diagnosed with immunoglobulin A nephropathy (IgAN).</p> |
